-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

904.O2.6 904. Outcomes Research - Non-Malignant Conditions: Sickle Cell Disease and Beta Thalassemia

Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
sickle cell disease, Adult, Anemias, Biological, Diseases, Non-Biological, thalassemia, Therapies, Pediatric, Hemoglobinopathies, gene therapy, Study Population, Clinically relevant, Quality Improvement , transfusion
Sunday, December 6, 2020: 9:30 AM-11:00 AM
Susanna A Curtis, MD, MS, Yale University and Cecelia Calhoun, MD, Washington University School of Medicine in St Louis
No relevant conflicts of interest to declare.
9:30 AM

Maria Domenica Cappellini1, Ali T. Taher, MD, PhD, FRCP2, Antonio Piga, MD3, Farrukh Shah4*, Ersi Voskaridou5*, Vip Viprakasit6*, John B. Porter, MA, M.D., FRCP, FRCPath7*, Olivier Hermine8,9*, Ellis J. Neufeld10, Alexis A. Thompson, MD11, Derek Tang12*, Peiwen Yu13*, Shien Guo13*, Jeevan K. Shetty12*, Dimana Miteva12*, Tatiana Zinger12*, Jay T. Backstrom14* and Esther Natalie Oliva, MD15

1University of Milan, Milan, Italy
2Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon
3Department of Clinical and Biological Sciences, University of Turin, Turin, Italy
4Department of Haematology, Whittington Health NHS Trust, London, United Kingdom
5Thalassemia and Sickle Cell Center of Laiko General Hospital, Athens, Greece
6Siriraj Hospital, Mahidol University, Bangkok, Thailand
7University College London Hospitals NHS Foundation Trust, London, United Kingdom
8Necker Hospital, Assistance Publique–Hôpitaux de Paris, Paris, France
9Imagine Institute, INSERM Unité 1163, University of Paris, Paris, France
10St. Jude Children's Research Hospital, Memphis, TN
11Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL
12Bristol Myers Squibb, Princeton, NJ
13Evidera, Waltham, MA
14Acceleron Pharma, Cambridge, MA
15Grande Ospedale Metropolitano Bianchi-Melacrino-Morelli, Reggio Calabria, Italy

9:45 AM

Julie Kanter, MD1, John F. Tisdale, MD2,3, Markus Y Mapara, MD, PhD4, Janet L. Kwiatkowski, MD, MSCE5,6, Lakshmanan Krishnamurti, MD7, Ren Chen8*, Meghan E. Gallagher, MSc8*, Yuchen Ding, PhD8*, Sunita Goyal, MD8*, Clark Paramore, MPH8*, Alexis A. Thompson, MD9,10 and Mark C. Walters, MD11

1University of Alabama at Birmingham, Birmingham, AL
2National Institutes of Health, Bethesda, MD
3Clinical and Molecular Therapeutics Branch, NHLBI / NIDDK, NIH, Bethesda, MD
4Columbia Center for Translational Immunology, Columbia University, New York, NY
5University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
6The Children's Hospital of Philadelphia, Philadelphia, PA
7Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta, Emory University, Atlanta, GA
8bluebird bio, Inc., Cambridge, MA
9Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, IL
10Northwestern University Feinberg School of Medicine, Chicago, IL
11UCSF Benioff Children's Hospital Oakland, Oakland, CA

10:00 AM

Zaria Williams1, Steven J. Hardy, PhD2,3*, Carly Berger4*, Danielle Griffin4*, Hannah Weisman4*, Hua Liang, PhD5* and Deepika S. Darbari, MD6,7,8

1Howard University College of Medicine, Washington, DC
2Center for Cancer and Blood Disorders, Children's National Health System, Washington, DC
3Departments of Pediatrics and Psychiatry & Behavioral Sciences, George Washington University School of Medicine and Health Sciences, Washington, DC
4Children's National Hospital, Washington, DC
5The George Washington University, Washington, DC
6Division of Hematology and Oncology, Children's National Medical Center, Washington, DC
7Center for Cancer and Blood Disorders, Children's National Medical Center, Washington, DC
8Pediatrics, The George Washington University School of Medicine, Washington, DC

10:15 AM

Shannon Phillips, PhD, RN1*, Julie Kanter, MD2, Martina Mueller, PhD1*, Kenneth Ruggiero, PhD1* and Teresa Kelechi, PhD, RN, FAAN1*

1College of Nursing, Medical University of South Carolina, Charleston, SC
2Hematology/Oncology, Comprehensive Sickle Cell Center, University of Alabama at Birmingham, Birmingham, AL

10:30 AM

Elaissa L. Hardy, PhD1,2,3*, Brenda Williams4*, Christopher Harden4*, Oluwamayokun Oshinowo5,6, Renee Copeland, BS6*, Beatrice Gee, MD7,8 and Wilbur A. Lam, MD, PhD1,6,9

1Department of Pediatrics, Division of Pediatric Hematology/Oncology, Emory University School of Medicine, Atlanta, GA
2Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta, Atlanta, GA
3Emory Univeristy, Atlanta, GA
4Children's Healthcare of Atlanta, Atlanta, GA
5Medical College of Georgia, Lagrange, GA
6Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA
7Morehouse School of Med., Atlanta, GA
8Children's At Hughes Spalding, Atlanta, GA
9Children’s Healthcare of Atlanta, Atlanta, GA

10:45 AM

Stéphanie Forté, MD, MSc, FRCPC1,2,3, Maryline Couette, PhD4,5*, Damien Oudin Doglioni, PhD6*, Denis Soulieres, MD7, Kevin H.M. Kuo, MD, MSc, FRCPC1,2 and Pablo Bartolucci, MD, PhD8,9,10*

1Division of Medical Oncology and Hematology, Department of Medicine, University Health Network, Toronto, ON, Canada
2Division of Hematology, Department of Medicine, University of Toronto, Toronto, ON, Canada
3Medicine, Centre hospitalier de l'Université de Montréal, Montréal, QC, Canada
4Medicine, CHU Henri Mondor, Créteil, France
5Neurorehabilitation Department, Hôpital Albert Chenevier, Créteil, France
6CHU Henri Mondor, Créteil, France
7Centre hospitalier de l'Université de Montréal, Montreal, QC, Canada
8Sickle cell referral center, Internal Medicine Unit, Henri Mondor Hospital, Assistance Publique-Hôpitaux de Paris, Creteil, France
9INSERM-U955, Equipe 2, Laboratoire D'Excellence, GRex, Institut Mondor, Créteil, France
10Henri Mondor Hospital - APHP, Creteil, France

*signifies non-member of ASH